1621525-09-4

Basic information

• Product Name: 3-(3-iodo-1H-pyrazol-1-yl)-5-(trifluoromethyl)pyridine
• Synonyms: 3-(3-iodo-1H-pyrazol-1-yl)-5-(trifluoromethyl)pyridine
• CAS NO: 1621525-09-4
• Molecular Weight: 339.059
• Mol File: 1621525-09-4.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 3-(3-iodo-1H-pyrazol-1-yl)-5-(trifluoromethyl)pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(3-iodo-1H-pyrazol-1-yl)-5-(trifluoromethyl)pyridine(1621525-09-4)
• EPA Substance Registry System: 3-(3-iodo-1H-pyrazol-1-yl)-5-(trifluoromethyl)pyridine(1621525-09-4)

Safety Data

• Hazardous Substances Data: 1621525-09-4(Hazardous Substances Data)

Upstream product

• 1099597-96-2 3-fluoro-5-(trifluoromethyl)pyridine 
• 4522-35-4 3-iodo-1H-pyrazole 

Relevant articles and documents

FACTOR IXA INHIBITORS

The present invention provides a compound of Formula (I) (structurally represented) wherein R1 is H or C1-6 alkyl, R2 is H or C1-6 alkyl or CH20H, R3 is H or C1-6 alkyl, and R4 is H or C1-6 alkyl, provided that when R1, R2, and R3 are H, R4 is C1-6 alkyl, and when R1, R2, and R4 are H, then R3 is C1-6 alkyl, and when R1, R3, and R4 are H, R2 is C1-6 alkyl or-CH20H, and when R2, R3, and R4 are H, then R1 is C 1-6 alkyl; A is 1 ) a 9-10 membered bicyclic heterocycle having 1-3 heteroatoms independently selected from N, S and 0, which 9-10 membered bicyclic heterocycle is unsubstituted or substituted with R5 and unsubstituted or substituted with R6 and unsubstituted or substituted with NH2, or 2) a 6-9 membered monocyclic or bicyclic carbocyclic ring system unsubstituted or substituted with R5, unsubstituted or substituted with R6, and unsubstituted or substituted with -CH2NH2; and B is 1) a 5- or 6-membered monocyclic heterocycle having 1 or 2 heteroatoms independently selected from N, S or 0, which is unsubstituted or substituted on a carbon or nitrogen atom with R7, unsubstituted or substituted on a carbon or nitrogen atom with R8, and unsubstituted or substituted on a carbon or nitrogen atom with R9, or 2) an 8- or 9-membered fused bicyclic heterocycle having 1, 2 or 3 nitrogen atoms which is unsubstituted or substituted on a carbon or nitrogen atom with R7, and unsubstituted or substituted on a carbon or nitrogen atom with R8; and pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing thromboses.